Literature DB >> 16571454

Schizophrenia, theory of mind, and persecutory delusions.

Leigh Harrington1, Robyn Langdon, Richard J Siegert, John McClure.   

Abstract

INTRODUCTION: There is already a substantial body of evidence supporting Frith's (1992) theory that theory of mind (ToM) is impaired in people with schizophrenia. However, a specific relationship between impaired ToM and paranoid delusions, while intuitively reasonable, has only been demonstrated in two studies to date.
METHODS: A total of 25 participants with schizophrenia were classified as paranoid or nonparanoid and compared with 38 healthy controls on a variety of ToM tasks. These tasks included verbal and nonverbal, and first and second order ToM tasks.
RESULTS: Participants with schizophrenia performed significantly more poorly than healthy controls on both the first and second order verbal ToM tasks but not on the nonverbal ToM tasks. However, the ToM deficit was only observed for those participants with schizophrenia who had persecutory delusions. There was also a strong relationship observed between the severity of persecutory delusions and length of illness.
CONCLUSIONS: This study represents only the third demonstration of a specific link between paranoid delusions and ToM impairment. Reasons why previous findings on this issue have been so inconsistent are considered. Further research is needed to explore the relationships among paranoia, ToM, and length of illness.

Entities:  

Year:  2005        PMID: 16571454     DOI: 10.1080/13546800344000327

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  18 in total

1.  Theory of Mind in Schizophrenia and Asperger's Syndrome: Relationship with Negative Symptoms.

Authors:  Halise Devrimci Ozguven; Ozgur Oner; Bora Baskak; Ferhunde Oktem; Senay Olmez; Kerim Munir
Journal:  Klinik Psikofarmakol Bulteni       Date:  2010

2.  Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Rachel C Wood; Gerhard S Hellemann
Journal:  Schizophr Bull       Date:  2011-07-15       Impact factor: 9.306

Review 3.  Identifying and assessing psychosis in deaf psychiatric patients.

Authors:  Sarah A Landsberger; David R Diaz
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 4.  Prefrontal cortical dopamine from an evolutionary perspective.

Authors:  Young-A Lee; Yukiori Goto
Journal:  Neurosci Bull       Date:  2015-01-23       Impact factor: 5.203

Review 5.  Development of rostral prefrontal cortex and cognitive and behavioural disorders.

Authors:  Iroise Dumontheil; Paul W Burgess; Sarah-Jayne Blakemore
Journal:  Dev Med Child Neurol       Date:  2008-01-11       Impact factor: 5.449

6.  A History of Psychosis in Bipolar Disorder is Associated With Gray Matter Volume Reduction.

Authors:  Carl Johan Ekman; Predrag Petrovic; Anette G M Johansson; Carl Sellgren; Martin Ingvar; Mikael Landén
Journal:  Schizophr Bull       Date:  2016-06-11       Impact factor: 9.306

7.  Normal sexual dimorphism in theory of mind circuitry is reversed in Schizophrenia.

Authors:  Julie Walsh-Messinger; Christine Stepanek; Julia Wiedemann; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  Soc Neurosci       Date:  2018-10-29       Impact factor: 2.083

8.  Understanding communicative intentions in schizophrenia using an error analysis approach.

Authors:  Alberto Parola; Claudio Brasso; Rosalba Morese; Paola Rocca; Francesca M Bosco
Journal:  NPJ Schizophr       Date:  2021-02-26

9.  A study of theory of mind in paranoid schizophrenia: a theory or many theories?

Authors:  Peter Scherzer; Edith Leveillé; André Achim; Emilie Boisseau; Emmanuel Stip
Journal:  Front Psychol       Date:  2012-11-14

10.  Dissociation of understanding from applying others' false beliefs in remitted schizophrenia: evidence from a computerized referential communication task.

Authors:  Yong-guang Wang; David L Roberts; Bai-hua Xu
Journal:  BMC Psychiatry       Date:  2013-05-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.